Daré Bioscience Receives Approximately $852,000 in Additional Grant Funding
Additional funding represents the second-to-last anticipated payment under the up to approximately $10.7 million grant agreement supporting preclinical development of a novel non-hormonal intravaginal contraceptive Additional funding represents the second-to-last anticipated payment under the up to approximately $10.7 million grant agreement supporting preclinical development of a novel non-hormonal intravaginal contraceptive